4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-20-000253
Chief Executive Officer acquired 8,586 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kummeth Charles R. Chief Executive Officer | 2020-08-05 | Grant or award | +8,586 | 152,483 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kummeth Charles R. Chief Executive Officer | 2020-08-05 | Grant or award · Restricted Stock Units | +12,879 | 12,879 | D: show line 2 in the form | |||||
| Kummeth Charles R. Chief Executive Officer | 2020-08-05 | Grant or award · Stock Options (Right to Buy) | +57,442 | 57,442 | D: show line 3 in the form | |||||
| Kummeth Charles R. Chief Executive Officer | 2020-08-05 | Grant or award · Stock Options (Right to Buy) | +38,295 | 38,295 | D: show line 4 in the form | |||||
| Kummeth Charles R. Chief Executive Officer | 2020-08-05 | Grant or award · Stock Options (Right to Buy) | +16,650 | 16,650 | D: show line 5 in the form | |||||
| Kummeth Charles R. Chief Executive Officer | 2020-08-05 | Grant or award · Stock Options (Right to Buy) | +16,650 | 16,650 | D: show line 6 in the form |
Loading xslF345X03/edgar.xml…